Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05803850
What this trial is testing

Evaluate the Safety, Tolerability, PK and PD of HNC1058

Who this might be right for
IPF
Guangzhou Henovcom Bioscience Co. Ltd. 32
Early research (Phase 1)UnknownNCT03645278
What this trial is testing

The PK/PD Study of SHR0532 Tablets in Healthy Subjects

Who this might be right for
Hypertension
Jiangsu HengRui Medicine Co., Ltd. 50
Testing effectiveness (Phase 2)Study completedNCT06922448
What this trial is testing

Study of BLU-808 in Allergic Rhinoconjunctivitis

Who this might be right for
Allergic Rhinoconjunctivitis
Blueprint Medicines Corporation 21
Early research (Phase 1)Study completedNCT02765633
What this trial is testing

Cangrelor Neonatal PK/PD and Safety Study

Who this might be right for
Partial Obstruction of Systemic to Pulmonary Artery ShuntComplete Obstruction of Systemic to Pulmonary Artery Shunt
Chiesi Farmaceutici S.p.A. 22
Early research (Phase 1)Looking for participantsNCT07235059
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Novartis Pharmaceuticals 112
Early research (Phase 1)Study completedNCT00457782
What this trial is testing

A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Multiple MyelomaChronic Lymphocytic LeukaemiaB-cell Non-Hodgkin's Lymphoma
Kyowa Kirin Co., Ltd. 27
Testing effectiveness (Phase 2)Ended earlyNCT05388435
What this trial is testing

Safety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients

Who this might be right for
Advanced Solid Tumor
SK Life Science, Inc. 15
Early research (Phase 1)Study completedNCT01870674
What this trial is testing

Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH12852 After Oral Administration in Healthy Male Subjects

Who this might be right for
Healthy
Yuhan Corporation 127
Early research (Phase 1)Ended earlyNCT03943550
What this trial is testing

Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Hoffmann-La Roche 45
Early research (Phase 1)Study completedNCT01835197
What this trial is testing

First-in-Human Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of Janus Kinase-1 Inhibitor PF-04965842 in Healthy Western and Japanese Subjects

Who this might be right for
Healthy
Pfizer 79
Early research (Phase 1)Study completedNCT02571855
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of ACT-541468 in Healthy Young Adults and Elderly Subjects

Who this might be right for
Healthy Subjects
Idorsia Pharmaceuticals Ltd. 85
Early research (Phase 1)Study completedNCT05006521
What this trial is testing

Single and Multiple Ascending Dose Study of KN-002

Who this might be right for
Asthma COPD
Kinaset Therapeutics Inc 117
Testing effectiveness (Phase 2)Study completedNCT02079896
What this trial is testing

Lexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis Patients

Who this might be right for
AnemiaEnd Stage Renal Disease
TME Pharma AG 33
Early research (Phase 1)Study completedNCT03062956
What this trial is testing

A Single Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of MYK-491

Who this might be right for
Dilated Cardiomyopathy
MyoKardia, Inc. 64
Early research (Phase 1)Ended earlyNCT03907202
What this trial is testing

A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM

Who this might be right for
Type II Diabetes Mellitus
KeyBioscience AG 25
Early research (Phase 1)Looking for participantsNCT07366866
What this trial is testing

Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults.

Who this might be right for
Autoimmune Disease
Changchun GeneScience Pharmaceutical Co., Ltd. 48
Early research (Phase 1)Looking for participantsNCT07368127
What this trial is testing

TPD3310 in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Solid Tumors
TAIBIDI PHARMACEUTICAL TECHNOLOGY(SHIJIAZHUANG) CO.,LTD. 112
Early research (Phase 1)Study completedNCT03522506
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy Adults

Who this might be right for
Healthy Volunteers
Takeda 20
Testing effectiveness (Phase 2)Study completedNCT03268941
What this trial is testing

Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)

Who this might be right for
Diabetes Mellitus and Gastroparesis, Idiopathic Gastroparesis
Millennium Pharmaceuticals, Inc. 51
Early research (Phase 1)Study completedNCT02148185
What this trial is testing

Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease

Who this might be right for
Crohn's Disease
Tanabe Pharma Corporation 1
Next Page